Samir Arora-backed Helios Mid Cap Fund added Aurobindo Pharma alongside two other equities and increased stakes in 19 existing holdings during October, according to portfolio disclosures on ACE MF.
The midcap fund acquired 2.54 lakh shares of Aurobindo Pharma, valuing the addition at Rs 42.74 crore. Portfolio disclosures show the fund also added 11.77 lakh shares of Zetwerk Manufacturing Businesses and 1.29 lakh shares of PVR Inox during the month.
Exposure expanded across 19 existing portfolio companies. Holdings in One97 Communications (Paytm) increased by 27,200 shares to reach a total of 5.10 lakh shares, up from 4.83 lakh shares in September. The fund also added 51,430 shares of the Multi Commodity Exchange of India (MCX), bringing its total position to 1.89 lakh shares.
Among other portfolio adjustments, the fund added 12.77 lakh shares of AceVector, lifting its total holding to 47.77 lakh shares.
Samir Arora backed #Helios Mid Cap Fund adds #AurobindoPharma, 2 others, increase stake in #Paytm, #MCX and 16 others#ETMarkets https://t.co/8Xfrpovw04
The fund liquidated its entire position in Park Medi World by selling 4.89 lakh shares, representing a market value of Rs 13.45 crore. Portfolio records indicate zero reductions across remaining equities.
| Asset Allocation & Performance Metrics | Details |
|---|---|
| Assets Under Management (AUM) | Rs 2,421 crore (as of October 31, 2026) |
| Top NAV Allocation by Stock | Coforge (~3.50%), Paytm (3.44%), Sona BLW Precision Forgings (2.74%) |
| Portfolio Sector Concentration | Finance (16.22%), Automobiles & Ancillaries (15.76%), Healthcare (11.21%), IT (10.04%) |
| Market Capitalization Breakdown | Mid caps (65.27%), Small caps (27.75%), Large caps (2.98%), Others (4%) |
| Inception Performance (CAGR) | 20.51% since March 13, 2025 launch (Benchmark: Nifty Midcap 150 – TRI) |
Total holdings across the fund reached 77 stocks in October, compared to 75 in September, distributed across 23 sectors. Total Assets Under Management stood at Rs 2,421 crore as of October 31, 2026, according to The Economic Times.
The fund’s capital is distributed across mid-caps at 65.27%, small-caps at 27.75%, large-caps at 2.98%, and other securities at 4%. Launched on March 13, 2025, the vehicle has generated a Compound Annual Growth Rate (CAGR) of 20.51% since inception.
Over the trailing six-month period, the fund returned 6.75%, compared to a loss of 0.85% by its benchmark, the Nifty Midcap 150 – TRI. Over the trailing one-year window, returns registered at 6.58% against the benchmark’s 2.24%.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
